Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06327399

Dexmedetomidine Infusion Dose Versus Rapid Bolus Dose Before Tracheal Intubation.

Effect of Dexmedetomidine Infusion Dose Versus Rapid Bolus Dose on Hemodynamic Changes During Laryngoscopy and Tracheal Intubation in Adults. A Randomized Comparative Study.

Sponsor: Kasr El Aini Hospital

Conditions Dexmedetomidine Intubation Complication

Interventions Atropine Sulfate Dexmedetomidine bolus Dexmedetomidine infusion Ephedrine Propofol

Updated 3 times since 2024 Last updated: Mar 17, 2024 Started: Jan 21, 2024 Primary completion: Apr 30, 2024 Completion: May 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Dexmedetomidine and Intubation Complication and is currently actively recruiting participants. Kasr El Aini Hospital leads this study, which shows 3 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Apr 2024 — Jul 2024 [monthly]

Recruiting PHASE2

First recorded

Jan 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kasr El Aini Hospital

Data source: Kasr El Aini Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Giza, Egypt